Search filters

List of works by Patrick Terheyden

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study

scientific article published on 13 November 2019

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

scientific article

Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.

scientific article

Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients

scientific article published on 01 October 2020

Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG

scientific article published on 01 May 2020

Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders

scientific article published on 27 February 2018

Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors

scientific article published on 17 November 2018

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma.

scientific article

Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG)

scientific article published on 21 November 2020

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

scientific article

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

scientific article published on 16 February 2017